Journey Medical Corp (DERM)
5.60
+0.46
(+8.95%)
USD |
NASDAQ |
Jun 28, 16:00
5.60
0.00 (0.00%)
After-Hours: 16:48
Journey Medical Research and Development Expense (TTM): 13.39M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 13.39M |
| December 31, 2023 | 7.541M |
| September 30, 2023 | 10.29M |
| June 30, 2023 | 10.88M |
| March 31, 2023 | 11.71M |
| December 31, 2022 | 10.94M |
| September 30, 2022 | 8.679M |
| Date | Value |
|---|---|
| June 30, 2022 | 6.661M |
| March 31, 2022 | 17.82M |
| December 31, 2021 | 16.56M |
| September 30, 2021 | 14.57M |
| June 30, 2021 | 13.77M |
| March 31, 2021 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
Mar 2021
17.82M
Maximum
Mar 2022
10.99M
Average
10.94M
Median
Dec 2022
Research and Development Expense (TTM) Benchmarks
| Fortress Biotech Inc | 91.40M |
| Stereotaxis Inc | 9.77M |
| GT Biopharma Inc | 5.593M |
| Cara Therapeutics Inc | 106.14M |
| Voyager Therapeutics Inc | 100.70M |